Labcorp Holdings Inc. (LH:NYSE) closed at $328.95 on October 23, 2026, down 0.30% on the day. The stock trades 3.8% below its 52-week high of $341.80 and 34.5% above its 52-week low of $244.52. Over the past year, it gained 17.7%. Labcorp Holdings Inc. is part of the Health Care sector (Medical Specialities).
In 252 trading sessions since October 23, 2025, LH closed higher on 126 days (50%). Its best day was July 28, 2026 (+4.34%) and its worst was October 28, 2025 (-5.79%). It never moved 10% or more in a single session.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. It also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, the company provides drug development solutions, as well as laboratory testing services. Furthe...
Find more stocks like LH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.